461 related articles for article (PubMed ID: 17034025)
21. Hypersensitivity to plasma exchange in a patient with thrombotic thrombocytopenic purpura.
Lalmuanpuii J; Yalamanchili K; Fircanis S; Nelson JC
J Clin Apher; 2009; 24(1):18-20. PubMed ID: 19073012
[TBL] [Abstract][Full Text] [Related]
22. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
Suvajdzić-Vuković N
Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
[TBL] [Abstract][Full Text] [Related]
23. A case of mixed connective tissue disease complicated with thrombotic thrombocytopenic purpura.
Kuroda T; Matsuyama K; Nakatsue T; Murakami S; Hasegawa H; Nakayama H; Sakatsume M; Ueno M; Nakano M; Gejyo F
Clin Rheumatol; 2007 Jan; 26(1):101-4. PubMed ID: 16391894
[TBL] [Abstract][Full Text] [Related]
24. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
[TBL] [Abstract][Full Text] [Related]
25. Thrombotic thrombocytopenic purpura in childhood: an uncommon but life-threatening cause of thrombocytopenia.
Davis A; Barnes C
J Paediatr Child Health; 2007 Sep; 43(9):640-2. PubMed ID: 17688649
[TBL] [Abstract][Full Text] [Related]
26. Successful management of thrombotic thrombocytopenic purpura in a Jehovah's Witness without plasma exchange.
Chai W; Chaudhry A; Rabinowitz AP
J Clin Apher; 2015 Feb; 30(1):46-9. PubMed ID: 24782109
[TBL] [Abstract][Full Text] [Related]
27. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura in pediatric patients.
Steele M; Chen HH; Steele J; Chan AK; Lau KK
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):803-10. PubMed ID: 23146723
[TBL] [Abstract][Full Text] [Related]
29. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
Katagiri H; Kawai Y; Sugizaki N; Sakai K; Handa M; Okamoto S; Watanabe K
Rinsho Byori; 2003 Jun; 51(6):516-21. PubMed ID: 12884737
[TBL] [Abstract][Full Text] [Related]
30. Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China.
Deng MY; Zhang GS; Zhang Y; Xiao H; Dai CW; Xu YX; Zheng WL; Peng HL; Shen JK
Transfus Apher Sci; 2013 Dec; 49(3):447-52. PubMed ID: 23973730
[TBL] [Abstract][Full Text] [Related]
31. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
Korczowski B
Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura.
Tsai HM
Kidney Int Suppl; 2009 Feb; (112):S11-4. PubMed ID: 19180123
[TBL] [Abstract][Full Text] [Related]
33. ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait.
Al-Awadhi AM; Jadaon MM; Al-Jafar HA; Al-Wazzan HJ
Acta Haematol; 2011; 125(3):160-6. PubMed ID: 21196718
[TBL] [Abstract][Full Text] [Related]
34. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
[TBL] [Abstract][Full Text] [Related]
35. Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.
Rock G; Anderson D; Clark W; Leblond P; Palmer D; Sternbach M; Sutton D; Wells G; ;
Br J Haematol; 2005 Apr; 129(1):79-86. PubMed ID: 15801959
[TBL] [Abstract][Full Text] [Related]
36. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic plasma exchange for thrombotic thrombocytopenic purpura with refractory thrombocytopenia.
Maloney N; Martin I; Szczepiorkowski ZM; Dunbar NM
J Clin Apher; 2018 Jun; 33(3):436-438. PubMed ID: 29270999
[TBL] [Abstract][Full Text] [Related]
38. Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma.
Kentouche K; Budde U; Furlan M; Scharfe V; Schneppenheim R; Zintl F
Acta Paediatr; 2002; 91(10):1056-9. PubMed ID: 12434890
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
[TBL] [Abstract][Full Text] [Related]
40. The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.
Raife TJ; Friedman KD; Dwyre DM
Transfusion; 2006 Jan; 46(1):74-9. PubMed ID: 16398733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
